Search Results 1301-1310 of 21394 for anti-TNF drugs

  1. Fam-Trastuzumab Deruxtecan-Nxki (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  2. Olaratumab (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  3. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

  4. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

    The purpose of this study is to evaluate whether CRS-207 with pembrolizumab is safe and effective in adults with MPM who have failed prior anti-cancer therapy.

  5. Ethionamide (Oral Route) Description and Brand Names - Mayo Clinic

    Ethionamide is used together with other medicines to treat tuberculosis (TB). Ethionamide belongs to the class of medicines called antibiotics and works to kill ...

  6. Tretinoin (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Ziprasidone (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Telaprevir (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Selinexor Treatment of Refractory Myeloma - Mayo Clinic

    ... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...

  10. Resorcinol And Sulfur (Topical Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. Canadian Brand Name. Acne-Aid Gel; Acnomel Skin Tone; Acnomel Vanishing ...